Vol 15 No 2 (2021): Supplementary
Case Report

INCIDENCE OF HIGH GRADE QTCF PROLONGATION AND ITS MANAGEMENT AMONG PATIENTS UNDERGOING TREATMENT FOR DRUG RESISTANT TUBERCULOSIS (DR-TB): CASE SERIES.

Meseret Asfaw
PIH
Davd Lee Holtzman
Partners in Heath Lesotho
Bio
Gene F. Kwan
Partners in Health Boston and Boston University
Bio
lawrence T. Oyewusi
Partners in Heath Lesotho
Bio
carole D. Mitnick
Partners in Health Boston and Harvard University Medical School
Bio
Kwanjune J. Seung
Partners in Health Boston and Brigham women's hospital
Bio
Published September 1, 2021
Keywords
  • QT-interval Prolongation, Bedaquiline, Delamanid
How to Cite
Asfaw, M., Holtzman, D., Kwan, G., Oyewusi, lawrence, Mitnick, carole, & Seung, K. (2021). INCIDENCE OF HIGH GRADE QTCF PROLONGATION AND ITS MANAGEMENT AMONG PATIENTS UNDERGOING TREATMENT FOR DRUG RESISTANT TUBERCULOSIS (DR-TB): CASE SERIES. African Journal of Infectious Diseases (AJID), 15(2), 38-41. https://doi.org/10.21010/ajid v15n2S5

Abstract

QT-Prolongation